ATE483030T1 - Neue polynukleotid- und polypeptidsequenzen und deren verwendungen - Google Patents

Neue polynukleotid- und polypeptidsequenzen und deren verwendungen

Info

Publication number
ATE483030T1
ATE483030T1 AT03762257T AT03762257T ATE483030T1 AT E483030 T1 ATE483030 T1 AT E483030T1 AT 03762257 T AT03762257 T AT 03762257T AT 03762257 T AT03762257 T AT 03762257T AT E483030 T1 ATE483030 T1 AT E483030T1
Authority
AT
Austria
Prior art keywords
polypeptide sequences
new polynucleotide
polynucleotide
new
dega
Prior art date
Application number
AT03762257T
Other languages
English (en)
Inventor
Daniel Pereira
Original Assignee
Imclone Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imclone Llc filed Critical Imclone Llc
Application granted granted Critical
Publication of ATE483030T1 publication Critical patent/ATE483030T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT03762257T 2002-06-28 2003-06-30 Neue polynukleotid- und polypeptidsequenzen und deren verwendungen ATE483030T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39267502P 2002-06-28 2002-06-28
PCT/US2003/020601 WO2004003165A2 (en) 2002-06-28 2003-06-30 Novel polynucleotide and polypeptide sequences and uses thereof

Publications (1)

Publication Number Publication Date
ATE483030T1 true ATE483030T1 (de) 2010-10-15

Family

ID=30000915

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03762257T ATE483030T1 (de) 2002-06-28 2003-06-30 Neue polynukleotid- und polypeptidsequenzen und deren verwendungen

Country Status (9)

Country Link
US (1) US20070128595A1 (de)
EP (2) EP2275573A1 (de)
JP (1) JP4416650B2 (de)
AT (1) ATE483030T1 (de)
AU (1) AU2003261102A1 (de)
CA (1) CA2491083A1 (de)
DE (1) DE60334400D1 (de)
ES (1) ES2350828T3 (de)
WO (1) WO2004003165A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1578797A1 (de) * 2002-12-13 2005-09-28 Licentia Ltd. Das transmembranproteinamigo und dessen verwendungen
CN101460849B (zh) 2006-04-18 2013-02-13 株式会社英仙蛋白质科学 胰腺癌的诊断药和治疗药
JP2009544287A (ja) * 2006-07-20 2009-12-17 ノバルティス アーゲー 癌を処置、診断、または検出するためのａｍｉｇｏ−２インヒビター
JP2010280568A (ja) * 2007-09-21 2010-12-16 Perseus Proteomics Inc 肺癌、前立腺癌、乳癌、卵巣癌、及びメラノーマの診断薬および治療剤
JP2011001267A (ja) * 2007-10-17 2011-01-06 Univ Of Tokyo 大腸癌治療薬

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
US5464764A (en) 1989-08-22 1995-11-07 University Of Utah Research Foundation Positive-negative selection methods and vectors
WO2001053455A2 (en) * 1999-12-23 2001-07-26 Hyseq, Inc. Novel nucleic acids and polypeptides
ES2289630T3 (es) * 1999-03-08 2008-02-01 Genentech, Inc. Composiciones y procedimientos para el diagnostico de tumores.
CA2399776A1 (en) * 2000-02-03 2001-08-09 Hyseq, Inc. Novel nucleic acids and polypeptides
JP2003135075A (ja) * 2001-11-05 2003-05-13 Research Association For Biotechnology 新規な全長ｃＤＮＡ
EP1578797A1 (de) * 2002-12-13 2005-09-28 Licentia Ltd. Das transmembranproteinamigo und dessen verwendungen

Also Published As

Publication number Publication date
EP2275573A1 (de) 2011-01-19
JP2006508641A (ja) 2006-03-16
WO2004003165A2 (en) 2004-01-08
EP1572952A2 (de) 2005-09-14
DE60334400D1 (de) 2010-11-11
EP1572952B1 (de) 2010-09-29
WO2004003165A3 (en) 2006-07-20
ES2350828T3 (es) 2011-01-27
JP4416650B2 (ja) 2010-02-17
EP1572952A4 (de) 2007-08-29
CA2491083A1 (en) 2004-01-08
WO2004003165A9 (en) 2004-04-01
AU2003261102A1 (en) 2004-01-19
AU2003261102A8 (en) 2004-01-19
US20070128595A1 (en) 2007-06-07

Similar Documents

Publication Publication Date Title
ATE444967T1 (de) Spezifische bindungsmittel von human angiopoietin-2
NZ593289A (en) Anti-neuropilin-1 antibodies for treating angiogenesis
ATE536188T1 (de) Fcgammariib-spezifische antikörper und verfahren zur verwendung davon
ATE541590T1 (de) Modifizierte antikörper-fragmente
CY1112055T1 (el) Συνθεσεις και μεθοδοι για την διαγνωση και θεραπευτικη αγωγη ογκου πνευμονα
DK1615952T3 (da) Fremgangsmåder til behandling af betændelsestilstande med specifikke, til humant angiopoietin-2-bindende midler
EA200701448A1 (ru) Специфически связывающаяся с крипто-антигеном человека молекула (варианты), композиция на ее основе (варианты), способ получения молекулы, способ лечения посредством молекулы (варианты) и способ ингибирования крипто-экспрессии в клетке больного
DE69930872D1 (de) Antikörper gegen verkürzten vegf-d und deren verwendungen
DE60223547D1 (de) Gangliosid-assoziierte rekombinante antikörper und deren verwendung bei der diagnose und behandlung von tumoren
ATE407698T1 (de) Zusammensetzungen und verfahren zur behandlung von entzündlicher darmerkrankung
ATE483806T1 (de) Polynukleotide, welche für mitglieder der humanen b lymphozyten-aktivierendes antigen familie kodieren, und von diesen kodierte polypeptide
PT991421E (pt) Deteccao e modulacao das iap e naip para o diagnostico e tratamento de doenca proliferativa
MXPA05011085A (es) Composiciones y metodos relacionados a stop-1.
EA200801174A1 (ru) Антитела-миметики glp-2, полипептиды, композиции, способы и применения
WO2003087138A3 (en) Methods for identifying polypeptide factors interacting with rna
DE60334400D1 (de) Neue polynukleotid- und polypeptidsequenzen und deren verwendungen
BRPI0407031A (pt) Composições e métodos para tratamento de câncer empregando igsf9 e liv-1
DE602006018424D1 (de) Peptide zum nachweis von ehrlichia ewingii antikörper
DE60335610D1 (de) Neoplasma-spezifische antikörper und deren verwendungen
ATE386050T1 (de) Peptide, die die heparinbindungsdomäne von vegf und vegfr-2 binden
ATE543833T1 (de) Bmp-7-varianten-zusammensetzungen, verfahren und verwendungen
DE60230822D1 (de) Peptide mit homing für lymphgefässtumor und ihre verwendung
WO2005094159A3 (en) Methods of identifying neoplasm-specific antibodies and uses thereof
WO2004081027A3 (en) Neoplasm specific antibodies and uses thereof
EP1565200A4 (de) NUKLEINSûURE ENTSPRECHENDES PROTEIN 24P4C12 ZUR BEHANDLUNG UND ERKENNUNG VON KREBS

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties